| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Tierney David S is a Director at CATALYST PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 8 buys and 5 sells.
Estimated insider holdings value: $12.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sale+OE | 26,000 | $20.20 | $525,200.00 | -6.4% | +16.8% | - | |
| Aug 21, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $20.10 | $301,455.00 | -4.1% | +4.5% | +0.4% | |
| Apr 8, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sale+OE | 25,000 | $15.68 | $392,000.00 | -6.7% | -0.4% | +38.0% | |
| Dec 12, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sale+OE | 50,000 | $13.33 | $666,250.00 | -13.0% | +20.6% | +64.6% | |
| Apr 5, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $16.83 | $504,900.00 | -8.7% | -25.2% | -10.7% | |
| Mar 9, 2023 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 5,000 | $4.15 | $20,731.50 | +85.7% | +27.3% | +43.5% | |
| May 25, 2022 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 2,000 | $4.39 | $8,780.00 | +52.2% | +26.0% | +12.9% | |
| Nov 30, 2021 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 2,000 | $7.79 | $15,578.00 | +109.0% | -24.3% | -39.2% | |
| Aug 18, 2020 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 10,000 | $0.65 | $6,531.75 | +10.7% | - | - | |
| Mar 20, 2017 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 1,000 | $4.20 | $4,199.90 | +20.0% | - | - |